Completed OBSERVATIONAL NCT01356927

Same-day Long-acting Reversible Contraception for Medication Abortion (SaLMA)

Etonogestrel Implant or Depot Medroxyprogesterone Acetate for Medication Abortion

Sponsor: Boston University

Updated 8 times since 2017 Last updated: Apr 6, 2017 Started: May 31, 2011 Primary completion: Apr 30, 2014 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Abortion; Induced and is currently completed. Boston University leads this study, which shows 8 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 3 earlier versions

May 2017 — Apr 2018 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE2_PHASE3 → NA
Feb 2017 — May 2017 [monthly]

Unknown Status PHASE2_PHASE3
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Boston University
Family Planning Fellowship

Data source: Boston University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States